IL2 and neoplasm: Most importantly, proTα- and proTα(100–109)-matured DCs are also functionally competent to promote Th1-type immune responses in the presence of tumor-associated epitopes via the secretion of soluble mediators like tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and IL-2 [15].